Chronic Proton-Pump Inhibitor Therapy and Fracture Risk in Women Aged Between 50 and 65 years: A Retrospective Case-Control Study

Introduction Chronic proton-pump inhibitor (PPI) prescription is on the rise in the last decade with an increased prevalence in the elderly population. For most patients, this class of drugs is the primary treatment for various diseases. Even though PPIs are generally safe, long-term use has been as...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Nimesh, Fayed, Mohamed, Faldu, Priyansh, Maroun, Wissam, Chandarana, Janki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512296/
https://www.ncbi.nlm.nih.gov/pubmed/36176864
http://dx.doi.org/10.7759/cureus.28429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512296/
https://www.ncbi.nlm.nih.gov/pubmed/36176864
http://dx.doi.org/10.7759/cureus.28429

Ejemplares similares